This timeline of progressive label modifications raises questions about Ozempics warning label adequacy, what manufacturers knew, when they knew it, and whether early patients received adequate warnings before these updates occurred
[DOI] [PMC free article] [PubMed] [Google Scholar] 83.Takeda H., Tominari T., Hirata M., Watanabe K., Matsumoto C., Grundler F.M.W., Inada M., Miyaura C
How often should blood work be performed on a GLP-1 medicine
Deleterious off-target effects in women 10 years or more past menopause, such as ovarian, endometrial, and breast cancers, intravascular thrombosis, cardiovascular episodes, and stroke, and suppression of endogenous testosterone and libido and increased risk of prostate cancer in men, have precluded broad clinical applications (Stevenson and Thornton, 2007)
Diabetes Care 2022;45:909-18
Order: 1box Purity: 99